Patents Assigned to Neuro Code Tech Holdings, LLC
  • Patent number: 9707403
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: July 18, 2017
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 9636507
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: May 2, 2017
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 9492478
    Abstract: A bioelectronic medical method and system for rapidly destroying living cancer cells and the tumors they create including metastatic off-spring of such tumor(s) regardless of their location within a human or animal body. Calcium ions can be inserted into a nucleus of a cancer cell(s). The nucleus of the cancer cell(s) is then fragmented among many cancer cells (e.g., in a tumor) simultaneously with the transmission of a destructive analog electrically encoded signals to provide a medical cancer treatment thereof. A first target of medical cancer treatment is aimed principally into the nucleus and mitochondrion bodies of a malignancy associated with the cancer cell(s).
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: November 15, 2016
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 9440083
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: September 13, 2016
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 9295835
    Abstract: A bioelectronic medical method and system for rapidly destroying living cancer cells and the tumors they create including metastatic off-spring of such tumor(s) regardless of their location within a human or animal body. Calcium ions can be inserted into a nucleus of a cancer cell(s). The nucleus of the cancer cell(s) is then fragmented among many cancer cells (e.g., in a tumor) simultaneously with the transmission of a destructive analog electrically encoded signals to provide a medical cancer treatment thereof. A first target of medical cancer treatment is aimed principally into the nucleus and mitochondrion bodies of a malignancy associated with the cancer cell(s).
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: March 29, 2016
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 8831738
    Abstract: A method and apparatus for recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. A confounding signal is created for retransmission into the cells of a malignant tumor to damage the cell and cause apoptosis. The invention uses ultra low voltage and current to cause apoptosis.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: September 9, 2014
    Assignee: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner
  • Publication number: 20140228910
    Abstract: A scientific computer system with processor capable of recording, storing, and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Application
    Filed: February 18, 2014
    Publication date: August 14, 2014
    Applicant: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor Schuler, James K. Poliner, Donald E. Nash
  • Patent number: 8656930
    Abstract: A scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: February 25, 2014
    Assignee: Neuro-Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, James K. Poliner, Donald E. Nash
  • Patent number: 8315712
    Abstract: A hybrid scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. Confounding electrical signals are stored in a scientific cancer cell signal processor of the computer system. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are re-programmed from cancer cell communication signals.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: November 20, 2012
    Assignee: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner